Retrospective study of patient enrolled in Medicare Advantage or commercially insured plans suggests older COVID-19 patients with hypertension taking ACE inhibitors had lower risk of COVID-19 hospitalisation

Study (n=10,000) found ACE inhibitors linked to ~40% lower risk of COVID-19 hospitalisation for Medicare Advantage patients (but not in younger, commercially insured group). However, there was no decrease in mortality risk in these patients once hospitalised with COVID-19.

Source:

Biospace Inc.